
Cimed & Co. owns 1 brand in our database. Browse the complete portfolio of Cimed & Co. subsidiaries and brands across various industries.
Company Type
private
Headquarters
Pouso Alegre, Minas Gerais, Brazil
Brand Portfolio
1 brands
What does Cimed & Co. own?
Cimed & Co. controls Grupo Cimed's pharmaceutical and consumer health businesses, including brands such as Carmed, Cimegripe, and Lavitan, plus a large OTC and generic medicines portfolio and an expanding consumer goods operation.
Is Cimed & Co. publicly traded?
No. It is a privately held, family-controlled holding company with no stock listing. It does publish consolidated financial statements.
Who founded Cimed & Co.?
The group was founded in 1977 by João Adibe Marques de Oliveira in Marília, São Paulo. It is now led by second-generation CEO João Adibe, with third-generation family members entering senior leadership.
Where is Cimed & Co. headquartered?
The group is headquartered in Pouso Alegre, Minas Gerais, Brazil, where its main manufacturing and administrative operations are concentrated.
Who owns Cimed & Co.?
The company is controlled by the Adibe Marques family across three generations. There are no disclosed outside institutional shareholders.
What is Cimed's financial performance?
In 2025 it reported net revenue of approximately R$3.07 billion, up 12.5 percent, and net income of R$196.7 million, down about 30 percent. It reported about R$1 billion in revenue in the first quarter of 2026 and targets R$10 billion annually by 2030.
No competing brands found in the same categories. This could be because Cimed & Co.operates in unique market segments or we're still building our competitor database.
Cimed & Co. maintains a diverse portfolio of 1 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Cimed & Co.provides valuable insights into market dynamics, product relationships, and corporate strategy.